Keywords: teva, 2nd-qtr, profit, up, 539m, world, generics
Teva's 2nd-qtr 2008 profit up 5% to $539M
Article | 18 August 2008
World generics giant Teva Pharmaceutical Industries saw net sales rise 18% year-on-year to $2.82 billion in the second quarter of 2008, beating analyst ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
